Cargando…
Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancer
Autores principales: | Lim, Jeong Uk, Woo, In Sook, Jung, Yun Hwa, Byeon, Jae Ho, Park, Chan Kwon, Kim, Tae Jung, Kim, Hyo Rim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219976/ https://www.ncbi.nlm.nih.gov/pubmed/25378985 http://dx.doi.org/10.3904/kjim.2014.29.6.830 |
Ejemplares similares
-
Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe
por: Walleser, Silke, et al.
Publicado: (2012) -
Erlotinib Induced Trichomegaly of the Eyelashes
por: Jeon, Sang-Hoon, et al.
Publicado: (2013) -
Plasma rich in growth factors for the treatment of rapidly progressing refractory corneal melting due to erlotinib in nonsmall cell lung cancer
por: Guarnieri, Adriano, et al.
Publicado: (2017) -
Comprehensive Comparison of 22C3 and SP263 PD-L1 Expression in Non-Small-Cell Lung Cancer Using Routine Clinical and Conditioned Archives
por: Kim, Sue Youn, et al.
Publicado: (2022) -
Optimal timing for local ablative treatment of bone oligometastases in non-small cell lung cancer
por: Lee, Jayoung, et al.
Publicado: (2023)